Replies to post #193396 on Biotech Values

[DewDiligence]

CELG-RCPT PR:

http://finance.yahoo.com/news/celgene-acquire-receptos-advancing-leadership-205800804.html

The nominal deal value is $7.2B. The premium relative to yesterday’s closing price is 18%. (RCPT popped today on news leakage.)